- MORGAN STANLEY$2.3K
Addex Therapeutics Ltd SWISS EXCHANGE:ADXN
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-12-31 · prior 2025-09-30.
New Positions(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| MORGAN STANLEY | 300 | +300 | $2.3K | +$2.3K | — |
Added To(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| UBS Group AG | 156 | +155 | $1.2K | +$1.2K | 15500.0% |
Reduced(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| GAMMA Investing LLC | 81 | -40 | $625 | -$519 | -33.0% |
| RHUMBLINE ADVISERS | 72 | 0 | $554 | -$101 | 0.0% |
| SBI Securities Co., Ltd. | 1 | -4 | $8 | -$39 | -80.0% |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-12-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| MORGAN STANLEY | 300 | $2.3K | +300 | — |
| UBS Group AG | 156 | $1.2K | +155 | 15500.0% |
| GAMMA Investing LLC | 81 | $625 | -40 | -33.0% |
| RHUMBLINE ADVISERS | 72 | $554 | 0 | 0.0% |
| SBI Securities Co., Ltd. | 1 | $8 | -4 | -80.0% |
New & Closed Positions this quarter
No managers exited their positions this quarter.
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for ADXN against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.